Literature DB >> 21787514

The 2011 IOM report on vitamin D and calcium requirements for north america: clinical implications for providers treating patients with low bone mineral density.

Clifford J Rosen1, J Christopher Gallagher.   

Abstract

Vitamin D is an essential nutrient for skeletal mineralization and maintenance of bone mass. Most healthy individuals can meet their vitamin D requirements through dietary means, modest supplementation and solar exposure for short periods of time. The serum level of 25OHD that determines adequacy is 20 ng/ml, which corresponds with consumption of 6-800 IU of vitamin D per day, according to the Institute of Medicine review. There is still debate about whether higher doses of vitamin D are required for treating patients with osteoporosis.
Copyright © 2011 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21787514     DOI: 10.1016/j.jocd.2011.03.004

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  29 in total

1.  Prevention, detection, and treatment of osteopenia and osteoporosis.

Authors:  Seymour Katz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-03

Review 2.  Male osteoporosis.

Authors:  Matthew T Drake; Sundeep Khosla
Journal:  Endocrinol Metab Clin North Am       Date:  2012-06-17       Impact factor: 4.741

3.  Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats.

Authors:  Caitlin S Latimer; Lawrence D Brewer; James L Searcy; Kuey-Chu Chen; Jelena Popović; Susan D Kraner; Olivier Thibault; Eric M Blalock; Philip W Landfield; Nada M Porter
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

4.  Vitamin D Deficiency Adds an Element of Risk to Insulin Resistance in Colorectal Neoplasms.

Authors:  Myong Ki Baeg; Myung-Gyu Choi; Sun-Hye Ko; Bo-Geun Park; Kyung-Do Han; Jae Myung Park; Bo-In Lee; In-Seok Lee; Sang-Woo Kim
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

5.  Can one or two high doses of oral vitamin D3 correct insufficiency in a non-supplemented rheumatologic population?

Authors:  D Stoll; J Dudler; O Lamy; D Hans; M A Krieg; B Aubry-Rozier
Journal:  Osteoporos Int       Date:  2012-03-17       Impact factor: 4.507

6.  Impact of 3-Monthly Vitamin D Supplementation Plus Exercise on Survival after Surgery for Osteoporotic Hip Fracture in Adult Patients over 50 Years: A Pragmatic Randomized, Partially Blinded, Controlled Trial.

Authors:  A Laiz; J Malouf; A Marin; V Longobardi; J de Caso; J Farrerons; J Casademont
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

7.  Comparative effectiveness of alendronate and zoledronic acid on bone mass improvement in transfusion-dependent thalassemia patients.

Authors:  Omid Reza Zekavat; Mohamadreza Bordbar; Sezaneh Haghpanah; Forough Saki; Asghar Bazrafshan; Haleh Bozorgi
Journal:  J Bone Miner Metab       Date:  2019-04-11       Impact factor: 2.626

8.  Vitamin D in "early" primary Sjögren's syndrome: does it play a role in influencing disease phenotypes?

Authors:  Chiara Baldini; Andrea Delle Sedie; Nicoletta Luciano; Pasquale Pepe; Francesco Ferro; Rosaria Talarico; Chiara Tani; Marta Mosca
Journal:  Rheumatol Int       Date:  2013-10-06       Impact factor: 2.631

9.  Compromised Activation of Vitamin D After Elective Surgery: A Prospective Pilot Study.

Authors:  Martin Blomberg Jensen; Henrik Husted; Poul Jannik Bjerrum; Anders Juul; Henrik Kehlet
Journal:  JBMR Plus       Date:  2018-05-22

10.  Inverse association between maternal 25OHD level and cord GLP-1/GIP concentrations.

Authors:  Shimpei Niwa; Hidetoshi Mezawa; Naoaki Kobayashi; Hiroyuki Ida; Mitsuyoshi Urashima
Journal:  Pediatr Res       Date:  2015-12-09       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.